Anatomy-based inverse planning dose optimization in HDR prostate implant: A toxicity study
Authors:
- Luc BeaulieuLBLuc Beaulieu
- Éric VigneaultÉVÉric Vigneault
- 1 June 2005
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 75 (3) , 318-324
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- High Dose Rate Brachytherapy as Prostate Cancer Monotherapy Reduces Toxicity Compared to Low Dose Rate Palladium SeedsJournal of Urology, 2004
- Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissueInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- High dose rate prostate brachytherapy: the California Endocurietherapy (CET) MethodRadiotherapy and Oncology, 2000
- Is there a subset of patients with PSA ? 20 ng/ml who do well after conformal beam radiotherapy?Radiation Oncology Investigations, 1999
- Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate glandRadiotherapy and Oncology, 1997
- Conformai external beam treatment of prostate cancerUrology, 1997
- Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/mlInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment … now!International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995